Profile data is unavailable for this security.
About the company
Jinyao Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production, and sales of steroid hormones and amino acid raw materials and preparations. The Company is mainly engaged in the production and sales of over 70 types of raw materials, including dexamethasone, prednisone, methylprednisolone, betamethasone, and amino acids, as well as several dosage forms such as injections, ointments, creams, hard capsules, pills, lyophilized powder injections, inhalation preparations, and tablets. The Company's products and solutions are mainly applied in the pharmaceutical industry. The Company mainly operates in the domestic and overseas markets.
- Revenue in CNY (TTM)2.87bn
- Net income in CNY16.30m
- Incorporated1999
- Employees2.88k
- LocationJinyao Pharmaceutical Co LtdNo. 221, Huanghai Road, Development ZoneTIANJIN 300457ChinaCHN
- Phone+86 2 260740048
- Fax+86 2 265277561
- Websitehttp://www.kingyork.biz/html/2/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Obio Technology Shanghai Corp Ltd | 244.64m | -294.16m | 4.52bn | 692.00 | -- | 2.97 | -- | 18.49 | -0.4578 | -0.4578 | 0.3819 | 2.35 | 0.1095 | 4.22 | 2.37 | 353,519.30 | -13.15 | -3.10 | -15.68 | -3.47 | -37.29 | 19.60 | -120.16 | -23.22 | 1.06 | -94.99 | 0.2068 | -- | 21.16 | 31.58 | -151.54 | -- | 36.17 | -- |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.39bn | -29.25m | 4.62bn | 1.75k | -- | 1.78 | -- | 1.93 | -0.1149 | -0.1149 | 5.84 | 5.93 | 0.4078 | 1.78 | 5.62 | 1,363,012.00 | -0.4978 | 2.04 | -0.8498 | 3.75 | 18.98 | 27.73 | -1.22 | 5.05 | 0.4035 | 0.6728 | 0.5007 | 78.73 | 7.02 | 12.42 | -211.00 | -- | 29.24 | -3.43 |
| Ningbo Menovo Pharmaceutical Co Ltd | 1.54bn | 99.48m | 4.64bn | 2.47k | 46.69 | 2.00 | -- | 3.01 | 0.4502 | 0.4502 | 7.00 | 10.49 | 0.329 | 1.23 | 5.91 | 623,207.90 | 2.34 | 3.98 | 3.68 | 6.21 | 32.03 | 34.08 | 7.11 | 12.00 | 0.7165 | 5.71 | 0.3482 | 11.27 | 12.85 | 3.07 | 476.64 | -15.04 | -11.37 | -8.68 |
| Jinyao Pharmaceutical Co Ltd | 2.87bn | 16.30m | 4.65bn | 2.88k | 278.98 | 1.54 | -- | 1.62 | 0.0153 | 0.0153 | 2.63 | 2.77 | 0.49 | 2.45 | 6.38 | 996,743.00 | 1.39 | 1.87 | 2.18 | 3.31 | 41.43 | 45.67 | 2.84 | 3.30 | 1.19 | 11.91 | 0.1563 | 65.00 | -15.00 | -0.6786 | 14.01 | -3.78 | -23.40 | 19.63 |
| Sinotherapeutics Inc | 480.48m | 98.59m | 4.70bn | 312.00 | 47.64 | 3.59 | -- | 9.77 | 0.2175 | 0.2175 | 1.06 | 2.89 | 0.333 | 2.74 | 4.51 | 1,539,987.00 | 6.83 | 10.22 | 7.32 | 11.26 | 43.78 | 65.76 | 20.52 | 31.88 | 11.08 | -- | 0.00002 | 13.77 | 70.61 | 29.80 | 109.09 | 94.07 | 32.01 | -- |
| Yabao Pharmaceutical Group Co Ltd | 2.27bn | 222.85m | 4.74bn | 3.61k | 21.56 | 1.72 | -- | 2.09 | 0.3177 | 0.3177 | 3.26 | 3.99 | 0.6462 | 3.42 | 6.66 | 629,532.00 | 5.51 | 4.01 | 6.54 | 5.38 | 50.46 | 56.75 | 8.53 | 5.86 | 2.49 | -- | 0.0418 | 54.27 | -7.69 | -2.46 | 21.60 | 77.16 | -26.08 | 71.88 |
| Pulike Biological Engineering Inc | 1.10bn | 143.67m | 4.87bn | 1.55k | 33.44 | 1.89 | -- | 4.41 | 0.4204 | 0.4204 | 3.22 | 7.45 | 0.3571 | 2.68 | 3.03 | 711,690.80 | 4.65 | 6.79 | 5.41 | 8.00 | 57.65 | 62.55 | 13.02 | 16.34 | 2.51 | 15.83 | 0.0005 | 61.54 | -16.77 | 9.47 | -46.82 | -3.21 | 7.28 | 14.87 |
| Shanghai Xiao Fang Pharmaceutical Co Ltd | 504.59m | 213.50m | 4.89bn | 404.00 | 22.78 | 4.63 | -- | 9.69 | 1.33 | 1.33 | 3.16 | 6.57 | 0.3795 | 3.71 | 4.85 | 1,248,981.00 | 16.06 | -- | 19.02 | -- | 65.40 | -- | 42.31 | -- | 3.47 | -- | 0.0017 | -- | 0.5748 | -- | 0.8074 | -- | -- | -- |
| Tibet Weixinkang Pharmaceutical Co Ltd | 1.17bn | 222.08m | 4.91bn | 689.00 | 21.96 | 3.22 | -- | 4.20 | 0.5136 | 0.5136 | 2.71 | 3.51 | 0.608 | 11.75 | 6.71 | 1,695,637.00 | 11.56 | 10.05 | 14.30 | 13.45 | 58.42 | 51.50 | 19.01 | 13.72 | 3.93 | -- | 0.0058 | 52.31 | -1.69 | 11.90 | 15.02 | 34.62 | 5.91 | 50.02 |
Data as of Feb 06 2026. Currency figures normalised to Jinyao Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 2.58m | 0.24% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.27m | 0.21% |
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 970.20k | 0.09% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 579.40k | 0.05% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 277.10k | 0.03% |
| Vanguard Fiduciary Trust Co.as of 30 Nov 2025 | 251.20k | 0.02% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2025 | 237.50k | 0.02% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 206.50k | 0.02% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2025 | 190.60k | 0.02% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2025 | 175.10k | 0.02% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
